Search
Eton Pharmaceuticals Inc
ETONAdd to Watchlist
46.420USD
-2.610-5.32%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.27BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Eton Pharmaceuticals Inc is 8.00, ranking 56 out of 155 in the Pharmaceuticals industry. The average price target is 29.00, with a high of 35.00 and a low of 26.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
54.750
Target Price
+17.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Eton Pharmaceuticals Inc
ETON
4
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Eton Pharmaceuticals Inc's expected revenue for the next quarter?
Eton Pharmaceuticals Inc's expected revenue is 27.11M.
What is Eton Pharmaceuticals Inc's price target?
Analysts forecast that Eton Pharmaceuticals Inc's price target is USD 29.00, with the highest forecast at USD 35.00 and the lowest forecast at USD 26.00.
How have Eton Pharmaceuticals IncETON's recent earnings per share performed?
The market expectation was USD 0.06, while Eton Pharmaceuticals IncETON's earnings per share (EPS) for the previous quarter was USD 0.06. EPS for the next quarter is expected at USD 0.12.
What is the analyst rating for Eton Pharmaceuticals Inc?
Based on the ratings of Eton Pharmaceuticals Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.